Pharmaceutical company's proprietor denied application to quash charges in inflated medicine purchases case.

The court denied the application to quash proceedings and the charge sheet against the pharmaceutical company proprietor accused of involvement in inflated medicine purchases and misappropriation of funds. The court found the evidence presented in the charge sheet, supported by the C.B.I., sufficient to establish a connection to the alleged offenses, rejecting the applicant's counsel's argument of insufficient evidence. The court referenced a previous judgment related to a similar case, emphasizing the seriousness of the allegations and conspiracy involving multiple pharmaceutical companies, leading to the dismissal of the application.

---

---

Issues:
Quashing of proceedings and charge sheet based on allegations of involvement in the transaction of purchasing medicines at exorbitant prices.

Analysis:
The judgment pertains to a 482 application seeking the quashing of proceedings and the charge sheet against the applicant, who is alleged to have engaged in the purchase of medicines at inflated prices. The charge sheet details the involvement of the applicant in transactions with various pharmaceutical companies, including forged tenders and misappropriation of funds. The applicant, a proprietor of pharmaceutical companies, is accused of being part of a conspiracy involving the submission of forged tenders and inflated billing for medicines. The evidence supporting these allegations is presented in the charge sheet and reiterated by the C.B.I.

The applicant's counsel argues that there is insufficient evidence to prosecute the applicant and that the alleged facts do not establish his connection to the offenses. Reference is made to a previous case involving similar grounds raised by another individual, which was dismissed by a learned Single Judge in a detailed judgment related to the NRHM scam. The arguments put forth by the applicant's counsel are deemed insufficient as the facts of misappropriation of government funds in the NRHM scam are considered to apply to the present case as well. Consequently, the court finds no basis to quash the proceedings or the charge sheet against the applicant.

In conclusion, the court rejects the application for quashing the proceedings and the charge sheet, citing the reasons provided in the previous judgment related to the NRHM scam and the lack of merit in the applicant's arguments. The judgment underscores the seriousness of the allegations against the applicant regarding the purchase of medicines at inflated prices and the conspiracy involving multiple pharmaceutical companies, leading to the dismissal of the application seeking relief from the charges.

---